Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RXDX Prometheus Biosciences

Watchlist
106.020
-1.320-1.23%
Close  02/08 16:00 ET
High
107.880
Open
107.880
Turnover
39.48M
Low
104.910
Pre Close
107.340
Volume
373.00K
Market Cap
4.92B
P/E(TTM)
Loss
52wk High
122.750
Shares
46.39M
P/E(Static)
Loss
52wk Low
21.500
Float Cap
3.39B
Bid/Ask %
-33.33%
Historical High
122.750
Shs Float
32.00M
Volume Ratio
0.53
Historical Low
16.110
Dividend TTM
--
Div Yield TTM
--
P/B
21.15
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.17%
Amplitude
2.77%
Avg Price
105.849
Lot Size
1
Float Cap
3.39B
Bid/Ask %
-33.33%
Historical High
122.750
Shs Float
32.00M
Volume Ratio
0.53
Historical Low
16.110
Dividend TTM
--
P/B
21.15
Dividend LFY
--
Turnover Ratio
1.17%
Amplitude
2.77%
Avg Price
105.849
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .
CEO: Mr. Mark C. McKenna
Market: NASDAQ
Listing Date: 03/12/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist